biejia ruangan

components: turtle shell, zedoray rhizome, peony root, Angelica sinensis, pseudo-ginseng, campanumaea pilosula, Astragalus, dried human placenta, plant worms, Baphicacanthus root and farsythio; for treatment of chronic hepatitis B

Also Known As:

Networked: 23 relevant articles (5 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Bai, Wenlin: 2 articles (01/2022 - 11/2014)
2.	Chen, Liang: 2 articles (01/2022 - 11/2014)
3.	Chen, Yan: 2 articles (01/2022 - 11/2014)
4.	Chen, Yongping: 2 articles (01/2022 - 11/2014)
5.	Dong, Zheng: 2 articles (01/2022 - 11/2014)
6.	Hu, Xiaoyu: 2 articles (01/2022 - 11/2014)
7.	Lei, Chunliang: 2 articles (01/2022 - 11/2014)
8.	Li, Qin: 2 articles (01/2022 - 11/2014)
9.	Lu, Wei: 2 articles (01/2022 - 11/2014)
10.	Rong, Guanghua: 2 articles (01/2022 - 11/2014)

Related Diseases

1.	Liver Cirrhosis (Hepatic Cirrhosis) 07/01/2013 - "In conclusion, Fufang Biejia Ruangan table is recommended to be taken twice a day for treating liver fibrosis in chronic hepatitis." 01/01/2022 - "Fufang Biejia Ruangan Tablet (FBRT) is widely used for the treatment of liver fibrosis. " 11/18/2022 - "It was shown that Fufang Biejia Ruangan Tablets can effectively improve liver function and relieve liver fibrosis, but future research should focus on rigorously designed, multicenter, and large randomized controlled trials." 11/18/2022 - "A randomized controlled trial of Fufang Biejia Ruangan Tablets was used to treat CHB liver fibrosis. " 01/01/2022 - "Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl4-induced liver fibrosis."
2.	Chronic Hepatitis B 12/01/2022 - "Herein, we show that adding a traditional Chinese medicine called Biejia-Ruangan compound to an antiviral reduced the risk of HCC in patients with chronic hepatitis B." 12/01/2007 - "Fufang Biejia Ruangan tablet is effective and safe in treatment of patients with chronic hepatitis B complicated with liver fibrosis." 11/18/2022 - "Meta-analysis was used to evaluate the efficacy of Fufang Biejia Ruangan Tablets in the treatment of chronic hepatitis B (CHB) liver fibrosis. " 01/01/2022 - "Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial." 04/01/2019 - "Effect of Fufang Biejia Ruangan Tablet on lowering biochemical and virological parameters of hepatic fibrosis in patients with chronic hepatitis B: Protocol for a systematic review and meta-analysis of randomized controlled trials and cohort studies."
3.	Fibrosis (Cirrhosis) 03/06/2020 - "The Fufang-Biejia-Ruangan pill (FBRP) is the first clinically approved anti-fibrosis herbal formula in China. " 07/15/2016 - "Fufang Biejia Ruangan Pill (FFBJ) is the first anti-fibrosis drug approved by the China State Food and Drug Administration, and has been demonstrated to have a good antifibrotic efficacy in China. " 07/15/2016 - "Identification of compounds in an anti-fibrosis Chinese medicine (Fufang Biejia Ruangan Pill) and its absorbed components in rat biofluids and liver by UPLC-MS." 08/28/2013 - "To explore the protective effect and the relevant mechanisms of Fufang Biejia Ruangan Pills (FFBJRGP) on hepatic fibrosis in vivo and in vitro. " 08/28/2013 - "Effects of Fufang Biejia Ruangan pills on hepatic fibrosis in vivo and in vitro."
4.	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/01/2004 - "To study the influence of compound Biejia Ruangan Prescription (CBRP) on extracelluar matrix in bleomycin induced pulmonary fibrosis rats. " 01/01/2004 - "[Influence of compound biejia ruangan prescription on extracelluar matrix in bleomycin induced pulmonary fibrosis rats]."
5.	Hepatocellular Carcinoma (Hepatoma) 01/01/2023 - "Reply to: "Biejia-Ruangan compound and incidence of hepatocellular carcinoma"." 01/01/2023 - "Biejia-Ruangan compound and incidence of hepatocellular carcinoma." 12/01/2022 - "Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B." 01/01/2021 - "This retrospective study aimed to assess the effects of minimal hepatic encephalopathy (MHE) and Biejia-Ruangan (BR) on first hospital readmission in nonalcoholic cirrhosis patients without previous overt hepatic encephalopathy (OHE) or hepatocellular carcinoma (HCC). "

Related Drugs and Biologics

1.	Tablets
2.	entecavir
3.	Proteins (Proteins, Gene)
4.	Connective Tissue Growth Factor
5.	Therapeutic Uses
6.	Messenger RNA (mRNA)
7.	Procollagen
8.	Laminin (Merosin)
9.	Hyaluronic Acid (Hyaluronan)
10.	Doxorubicin (Adriamycin)

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)
2.	Therapeutics
3.	Patient Readmission